Share on StockTwits

Equities researchers at Bank of America started coverage on shares of IMS Health Holdings (NYSE:IMS) in a research report issued on Wednesday, StockRatingsNetwork.com reports. The firm set a “buy” rating on the stock.

A number of other analysts have also recently weighed in on IMS. Analysts at Morgan Stanley initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set an “equal weight” rating and a $26.00 price target on the stock. Separately, analysts at Leerink Swann initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set an “outperform” rating and a $29.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set an “overweight” rating and a $28.00 price target on the stock. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $27.40.

Shares of IMS Health Holdings (NYSE:IMS) traded down 2.02% on Wednesday, hitting $24.70. 366,078 shares of the company’s stock traded hands. IMS Health Holdings has a 52-week low of $21.63 and a 52-week high of $25.36. The stock has a 50-day moving average of $23.70 and a 200-day moving average of $23.70. The company has a market cap of $8.198 billion and a price-to-earnings ratio of 62.40.

IMS Health Holdings, Inc is a global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.